Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tabalumab in active rheumatoid arthritis with methotrexate
NCT00785928Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2008
- Primary completion
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 2 trial of tabalumab in rheumatoid arthritis (RA), sponsored by Eli Lilly and Company. Started Oct 2008; status: completed.
02
Drugs
tabalumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00785928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785928.